BANNER WEB ESTRECHO 1900x200pix colgado2

ProgramME


  PRE-CONGRESS:
Fundamental and applied studies in poisoning – an overview of their role for the clinical toxicologist
DAY 1 - Wednesday May 26th DAY 2 - Thursday, May 27th DAY 3 - Friday, May 28th
08.45-09.00   WELCOME AND OPENING / INTRODUCTION TO THE CONFERENCE PLATFORM 

 WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM

WELCOME DAY 3 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM 

09.00-09.01 Welcome and opening CAUSTIC INGESTION SYMPOSIUM

APAMT SYMPOSIUM

DRUG FORMULATION AND ITS IMPORTANCE IN THE POISONED PATIENT

09.01-10.30 Session 1

10.30-11.00 Rest break Rest break AND Authors with posters (Morning grouping) 

Rest break AND Authors with posters (Morning grouping)

11.00-11.10 Session 2

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

LOUIS ROCHE LECTURE

11.10-11.35 Rest break / Authors with posters (Morning grouping) 

11.35-11.40
11.40-12.00 ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

Fellows meeting

Lunch
12.00-12.30 Authors with posters (Lunchtime grouping)

12.30-13.00 Lunch break Lunch Break Authors with posters (Lunchtime grouping)

Lunch
13.00-13.30 Authors with posters (Lunchtime grouping)

YOUNG INVESTIGATORS AWARD

EAPCCT GENERAL ASSEMBLY

13.30-13.45 ALCOHOL AS A CO-INGESTANT IN THE POISONED PATIENT

 
13.45-14.00 Session 3

14.00-14.15 COVID-19 SYMPOSIUM

14.15-15.15 TOXICOLOGY 2.0 SYMPOSIUM

15.15-15.30 Rest break
15.30-15.45 UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP

Rest break AND Authors with posters (Afternoon grouping) 

15.45-16.00 Session 4

Rest break AND Authors with posters (Afternoon grouping)

16.00-16.15 COVID-19 SYMPOSIUM (continued)

16.15-16.45 FELLOWS LECTURE

16.45-17.15 Rest break AND Authors with posters (Afternoon grouping)

17.15-17.30 End of Precongress symposium 2021 END OF DAY 1

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

17.30-17.40    
17.40-17.50 END OF DAY 2

17.50   END OF DAY 3
END OF EAPCCT 2021 VIRTUAL CONFERENCE

(CEST time)

Welcome and opening

TUESDAY 25th09:00 - 09:01
Martin Wilks, Switzerland, and Paul Dargan, United Kingdom

Add to calendar2021-05-25 09:00 2021-05-25 09:01 Europe/Madrid Welcome and opening Martin Wilks, Switzerland, and Paul Dargan, United KingdomEAPCCT 2021

Session 1

TUESDAY 25th09:01 - 10:30
Moderators: Martin Wilks, Switzerland, and Paul Dargan, United Kingdom
Add to calendar2021-05-25 09:01 2021-05-25 10:30 Europe/Madrid Session 1 Moderators: Martin Wilks, Switzerland, and Paul Dargan, United KingdomEAPCCT 2021

 
09:01-09:30 In silico studies: Modelling drug-induced liver injury using machine learning
Felix Hammann, University Hospital Bern, Switzerland
09:30 -10:00 Use of in vitro studies for prediction of clinical NPS toxicity
Dino Lüthi, Medical University of Vienna, Austria
10:00 -10:30 Animal models to understand the mechanisms of toxicity and optimise poisoning management
Bruno Mégarbane, Paris-Diderot University, France
At the end of this session the audience should be able to:
  • Explain the potential and limitations of machine learning and cheminformatics for drug induced liver injury.
  • Name at least one advantage and one disadvantage of in vitro research as predictor of the clinical toxicity of NPS.
  • To understand how experimental animal models are designed and to which level they contribute to understand toxicity in humans.

Rest break

TUESDAY 25th10:30 - 11:00
Add to calendar2021-05-25 10:30 2021-05-25 11:00 Europe/Madrid Rest break Rest break EAPCCT 2021

Session 2

TUESDAY 25th11:00 - 12:30
Moderators: Bruno Megarbane, France and Katrin Faber, Switzerland
Add to calendar2021-05-25 11:00 2021-05-25 12:30 Europe/Madrid Session 1 Moderators: Bruno Megarbane, France and Katrin Faber, SwitzerlandEAPCCT 2021

 
11:00 -11:30 Genomics, pharmacogenomics and genotyping, an overview for the clinical toxicologist
Alexander Jetter, University Hospital Zürich, Switzerland
11:30 -12:00 Identifying exposure biomarkers with metabolomics: the example of dioxin
Serge Rudaz, Université de Genève, Switzerland
12:00 -12:30 Pharmacokinetic-pharmacodynamic modelling in clinical toxicology
Lucie Chevillard, Paris Descartes University, France
At the end of this session the audience should be able to:
  • Describe the opportunities and the limits of pharmacogenomics in patient care.
  • Know how metabolomic approaches could be useful to tackle the impact of toxicant such as acute dioxin exposure on human metabolism.
  • Learn the interest of different methods of pharmacokinetics analysis and how to relate PK to the markers of intoxication (pharmacodynamic) to better understand the possible mechanisms involved.

Lunch break

TUESDAY 25th12:30 - 13.45

Add to calendar2021-05-25 12:30 2021-05-25 13:45 Europe/Madrid Lunch break Lunch breakEAPCCT 2021

Session 3

TUESDAY 25th13:45 - 15:15
Moderators: Evangelia Liakoni, Switzerland, and Geert Verstegen Belgium
Add to calendar2021-05-25 13:45 2021-05-25 15:15 Europe/Madrid Session 3 Moderators: Eva Liakoni, Switzerland, and Geert Verstegen BelgiumEAPCCT 2021

 
13:45 -14:15 Cell cultures: In vitro human cell cultures to predict drug toxicity
Dirk Steinritz, Institut für Pharmakologie und Toxikologie der Bundesweh, Münich, Germany
14:15 -14:45 A general roadmap to investigate the main mechanisms of mitochondrial toxicity
Bernard Fromenty, France
14:15 -15:15 Organ chips: principles and applications for clinical toxicology
Pierre-Jean Ferron, INSERM, Rennes, France
At the end of this session the audience should be able to:
  • Explain the benefit but also the limitations of in vitro cell culture models for predicting acute drug toxicity.
  • Describe how xenobiotics disrupt mitocondrial metabolic pathways and the methods of investigation for these.
  • Overview of the different models of organ on chips and organoids used to identify toxicity mechanism: from the clinical case to the cell biology laboratory.

Rest break

TUESDAY 25th15:15 - 15:45

Add to calendar2021-05-25 15:15 2021-05-25 15:45 Europe/Madrid Rest break Rest breakEAPCCT 2021

Session 4

TUESDAY 25th15:45 - 17:15
Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, Polonia
Add to calendar2021-05-25 15:45 2021-05-25 17:15 Europe/Madrid Session 4 Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, PoloniaEAPCCT 2021

 
15:45-16:15 Imaging in neuropharmacology: applications to clinical toxicology
Nicholas Tournier, CEA, Orsay, France
16:15-16:45 Neuro-electrophysiology - principles and applications in organophosphate poisoning
Tharaka Dassanayake,University of Peradeniya, Sri Lanka
16:45-17:15 Understanding individual differences from big data analysis of patient records
Heikki Nikkanen, Mount Auburn Hospital, Boston, USA
At the end of this session the audience should be able to:
  • Outline how PET imaging and specific biomarkers may be utilised to study kinetics and interactions in the CNS.
  • Outline the basis of neuroelectrophysiological tests that assess peripheral nerves, neuromuscular junctional transmission and the central nervous system in organophosphate poisoning.
  • Describe the strengths and weaknesses of manipulation of large data sets for meaningful research in toxicology.

End of Precongress symposium 2021

TUESDAY 25th17:15

Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, Polonia

Add to calendar2021-05-25 17:15 2021-05-25 17:30 Europe/Madrid End of Precongress symposium 2021 Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, PoloniaEAPCCT 2021

WELCOME AND OPENING / INTRODUCTION TO THE CONFERENCE PLATFORM

WEDNESDAY 26th08:45 - 09:00

Hosts: Horst Thiermann, EAPCCT President
Lotte Hoegberg, EAPCCT/SMC Chair

Add to calendar2021-05-26 08:45 2021-05-26 09:00 Europe/Madrid WELCOME AND OPENING / INTRODUCTION TO THE CONFERENCE PLATFORM Hosts: Thiermann, EAPCCT President Lotte Hoegberg, EAPCCT/SMC Chair EAPCCT 2021

CAUSTIC INGESTION SYMPOSIUM

WEDNESDAY 26th09:00 - 11:10

Moderators: Ingrid Berling, Australia and Davide Lonati, Italy
Add to calendar2021-05-26 09:00 2021-05-26 11:10 Europe/Madrid CAUSTIC INGESTION SYMPOSIUM Moderators: Ingrid Berling, Australia and Davide Lonati, ItalyEAPCCT 2021

 
09:00-09:20 Epidemiology of caustic ingestions in children and adults
Maren Hermans-Clausen, University Hospital, Freiburg, Germany
09:20-09:40 The role of CT in the assessment of oral caustic injury
Pierre Cattan, Saint-Louis Hospital, Paris, France
09:40-10:00 The role of endoscopy in the assessment of oral caustic injury
Filippo Torroni, Bambino Gesu' Children's Hospital, Rome, Italy
10:00-10:20 Risk factors for oesophageal stricture in alkali ingestion in children
Viorela Nitescu, Bucharest, Romania (2020- Abstract 199)
10:20-10:40 Effectiveness of endoscopic application of human collagen Type 1 in the treatment of oesophageal chemical burns
Anastasia Yu Simonova, Moscow, Russia (2021- Abstract 293)
10:40-11:00 Management of caustic injury and the indications for surgical intervention
Wolfram Kluwe, University Hospital, Freiburg, Germany
11:00-11:10 Questions & Answers to the Caustic Ingestion Symposium speakers
 
At the end of this session the audience should be able to:
  • Describe factors influencing outcome of caustic ingestions regarding patterns of exposure, characteristics of agent involved and age of exposed patients.
  • Outline the potential benefits of CT in the emergency management of caustic injuries and discuss the optimal use of endoscopy in the emergency management of caustic injuries in children.
  • Explain the main points of the pathophysiology of caustic injuries and describe the management in acute situations and in the follow up.

Rest break and AUTHORS WITH POSTERS (Morning grouping)

WEDNESDAY 26th11:10 - 11:40

Add to calendar2021-05-26 11:10 2021-05-26 11:40 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Morning grouping) Rest break and AUTHORS WITH POSTERS (Morning grouping)EAPCCT 2021

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

WEDNESDAY 26th | 11:40 - 12:30

Moderators: Maren Hermans-Clausen Germany and Patricia Casey, Ireland
Add to calendar2021-05-26 11:40 2021-05-26 12:30 Europe/Madrid ORAL PLATFORM AND SHORT ORAL PRESENTATIONS Maren Hermans-Clausen Germany and Patricia Casey, IrelandEAPCCT 2021

 
11:40-11:50 Characteristics and clinical features of patients attending UK emergency departments with analytically-confirmed exposure to the synthetic cannabinoid MDMB-4EN Pinaca
Simon Hl Thomas, Newcastle, United Kingdom (2021- Abstract 294)
11:50-12:10 Changing patterns of synthetic cannabinoid receptor agonists encountered in UK emergency departments
Simon Hl Thomas, Newcastle, United Kingdom (2021- Abstract 295)
12:10-12:20 Patterns of teenage heroin exposures reported to the US poison centres
Saumitra Vijay Rege, Charlottesville, Virginia, USA (2021- Abstract 296)
12:20-12:30 Questions & Answers to the Oral platform and Short Oral Presentation speakers

AUTHORS WITH POSTERS (Lunchtime grouping)

WEDNESDAY 26th13:00 - 13:30
Add to calendar2021-05-26 13:00 2021-05-26 13:30 Europe/Madrid AUTHORS WITH POSTERS (Lunchtime grouping) AUTHORS WITH POSTERS (Lunchtime grouping)EAPCCT 2021

ALCOHOL AS A CO-INGESTANT IN THE POISONED PATIENT

WEDNESDAY 26th | 13:30 - 15:30

Moderators: Michael Eddleston, United Kingdom and Knut Erik Hovda, Norway
Add to calendar2021-05-26 13:30 2021-05-26 15:30 Europe/Madrid ALCOHOL AS A CO-INGESTANT IN THE POISONED PATIENT Moderators: Michael Eddleston, United Kingdom and Knut Erik Hovda, NorwayEAPCCT 2021

 
13:30-13:50 Alcohol as a co-ingestant with stimulant recreational drugs and energy drinks
Chris Yates, SAMU 061 Balears, Palma de Mallorca, Spain
13:50-14:10 Alcohol as a co-ingestant with benzodiazepines and/or other CNS depressants
Tobias Zellner, TUM School of Medicine, Technical University of Munich, Munich, Germany
14:10-14:30 Interactions between alcohol and organophosphate insecticide poisoning
Michael Eddleston, University of Edinburgh, UK
14:30-14:50 Poisonings where ethanol may be acutely protective – paracetamol
Kim Dalhoff, Bispebjerg University Hospital, Copenhagen, Denmark
14:50-15:10 Poisoning where ethanol is protective - the toxic alcohols
Ken McMartin, Louisiana State University Health Sciences Center, Shreveport, USA
15:10-15:20 Fomepizole during continuous renal replacement therapy, an observational study
Yvonne Lao, Oslo, Norway (2021- Abstract 297)
15:20-15:30 Questions & Answers to the Alcohol as a Co-ingestant in the Poisoned Patient speakers

At the end of this session the audience should be able to:
  • Discuss mechanistically how alcohol complicates management of stimulant drug ingestion and provide specific examples.
  • Describe the effect of ethanol when co-ingested with CNS-depressants in regard to symptoms, clinical management and outcome.
  • Explain how blood alcohol concentration interacts with insecticide dosing to worsen outcome in OP insecticide poisoning.
  • Listing clinically relevant studies of the effect(s) of alcohol on paracetamol toxicity, explain the possible protective mechanism of alcohol and debate the pros and cons of alcoholuse in the treatment of paracetamol poisoning.
  • Describe how ethanol can be used to treat methanol and ethylene glycol poisonings .

Rest break and AUTHORS WITH POSTERS (Afternoon grouping)

WEDNESDAY 26th15:45 - 16:15

Add to calendar2021-05-26 15:45 2021-05-26 16:15 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Afternoon grouping) Rest break and AUTHORS WITH POSTERS (Afternoon grouping)EAPCCT 2021

FELLOWS LECTURE

WEDNESDAY 26th | 16:15-17:15

Moderators: Allister Vale, United Kingdom and Hugo Kupferschmidt, Germany
Add to calendar2021-05-26 16:15 2021-05-26 17:15 Europe/Madrid FELLOWS LECTURE Moderators: Allister Vale, United Kingdom and Hugo Kupferschmidt, GermanyEAPCCT 2021

 
16:15-16:20 Introduction
16:20-17:15 Inaugural Fellows Lecture: “Vaping Induced Lung Injury”
David Christiani, Harvard University , Boston, USA

At the end of this session the audience should be able to:
  • Understand the exposures contained in current electronic vaping products in common use.
  • Understand the Acura effects of vaping aerosol exposure on the henna lung.
  • Understand the clinical syndromes associated with vaping.
  • Understand management and prevention interventions in EVALI. 7

UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP

WEDNESDAY 26th | 15:30 - 15:45

Moderators: Alex Campbell, United Kingdom and Lotte Hoegberg, Denmark
Add to calendar2021-05-26 15:30 2021-05-26 15:45 Europe/Madrid UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP Moderators: Alex Campbell, United Kingdom and Lotte Hoegberg, Denmark EAPCCT 2021

 
15:30-15:45 STATUS: QT prolongation in poisoning, Activated Charcoal, Paracetamol
Sophie Gosselin, CISSS de la Montérégie-Centre, Montreal, Canada

END OF DAY 1

WEDNESDAY 26th | 17:15 - 17:30

Hosts: Allister Vale, United Kingdom and Hugo Kupferschmidt, Germany
Add to calendar2021-05-26 17:15 2021-05-26 17:30 Europe/Madrid UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP Hosts: Allister Vale, United Kingdom and Hugo Kupferschmidt, GermanyEAPCCT 2021

WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM

THURSDAY 27th08:45 - 09:00

Host: Alex Campbell, United Kingdom

Add to calendar2021-05-27 08:45 2021-05-27 09:00 Europe/Madrid WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM Host: Alex Campbell, United Kingdom EAPCCT 2021

APAMT SYMPOSIUM: TOXICOVIGILANCE DURING COVID-19 IN THE ASIAN-PACIFIC REGION

THURSDAY 27th | 09:00 - 10:30

Moderators: Nick Buckley, Australia and David Wood, United Kingdom
Add to calendar2021-05-27 09:00 2021-05-27 10:30 Europe/Madrid APAMT SYMPOSIUM: TOXICOVIGILANCE DURING COVID-19 IN ASIA-PACIFIC Moderators: Nick Buckley, Australia and David Wood, United KingdomEAPCCT 2021

 
09:00-09:05 Introduction to the session
Nick Buckley, Australia and David Wood, United Kingdom
09:05-09:25 Covid-19, disinfection and methanol poisoning: A report from Iran
Hossein Hassanian-Moghaddam, Iran
09:25-09:45 Toxic disasters in India during Covid-19 pandemic
Ashish Bhalla, India
09:45-10:00 Caveat Emptor: Covid-19 and impacts on surPRISE illicit drug poisonings in Australia
Thanjira Jiranantakan ,Australia
10:00-10:20 Ketamine Adulteration in Thailand: the issue of supply and demand during Covid-19
Summon Chomchai, Thailand
10:20-10:30 Questions & Answers to the Session

At the end of this session the audience should be able to:
  • Learn about significant toxic exposures during COVID-19 pandemic in Asia -Pacific area.
  • Understand key steps of toxicovigilance taken in an Asian Pacific context
  • Apply lessons learned about the signal identification, data gathering, risk assessment and responses measures to their local context.

Rest break and AUTHORS WITH POSTERS (Morning grouping)

THURSDAY 27th | 10:30-11:00

Add to calendar2021-05-27 10:30 2021-05-27 11:00 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Morning grouping) Rest break and AUTHORS WITH POSTERS (Morning grouping)EAPCCT 2021

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

THURSDAY 27th | 11:00 - 11:35

Moderators: Gabija Laubner, Lithuania and Katrin Faber, Switzerland

 
Add to calendar2021-05-27 11:00 2021-05-27 11:35 Europe/Madrid ORAL PLATFORM AND SHORT ORAL PRESENTATIONS Moderators: Gabija Laubner, Lituania and Katrin Faber, SwitzerlandEAPCCT 2021

 
11:00-11:20 Unintentional exposure to immediate-release Tramadol in ≤6-year old children: A nationwide French Poisons Control Centre study
Dominique Vodovar, Paris, France (2021- Abstract 298)
11:20-11:30 Enquiries to the National Poisons Information Centre, Ireland concerning patients
Myles Monaghan, Dublin, Ireland (2021- Abstract 299)
11:30-11:35 Questions & Answers to the Alcohol as a Co-ingestant in the Poisoned Patient speakers

FELLOWS MEETING

THURSDAY 27th | 11:40-12:30

Hosts: Allister Vale, Hugo Kupferschmidt, Ian Whyte

Add to calendar2021-05-27 11:40 2021-05-27 12:30 Europe/Madrid FELLOWS MEETING Hosts: Allister Vale, Hugo Kupferschmidt, Ian WhyteEAPCCT 2021

AUTHORS WITH POSTERS (Lunchtime grouping)

THURSDAY 27th | 12:30-13:00

Hosts: Allister Vale, Hugo Kupferschmidt, Ian Whyte

Add to calendar2021-05-27 12:30 2021-05-27 13:00 Europe/Madrid AUTHORS WITH POSTERS (Lunchtime grouping) AUTHORS WITH POSTERS (Lunchtime grouping)EAPCCT 2021

YOUNG INVESTIGATORS AWARD

THURDSDAY 27th | 13:00-14:00

Moderators: Mark Zammit, Malta and Piotr Kabata, Polonia
Add to calendar2021-05-27 13:00 2021-05-27 14:00 Europe/Madrid YOUNG INVESTIGATORS AWARD Moderators: Mark Zammit, Malta and Piotr Kabata, Polonia)EAPCCT 2021

 
13:00-13:05 Welcoming to the Young investigators award
13:05-13:20 A 2 bag intravenous acetylcysteine regimen results in fewer treatment delays in the management of paracetamol overdose
Anselm Wong, Australia (YIA 2021- Abstract 300)
13:20-13:35 Decision support for toxin prediction using artificial intelligence
Tobias Zellner, Munich Germany (YIA 2021 -Abstract 301)
13:35-13:50 "Flu" the Looking-Glass: observational poison center study evaluating adverse events secondary to flumazenil administration over time
Varun Vohra, USA (YIA 2021 -Abstract 302)
13:50-14:00 Collection of votes and Announcement of the winner of YIA

COVID-19 SYMPOSIUM

THURDSDAY 27th | 14:00-15:30

Moderators: Evangelia Liakoni, Switzerland and Erik Lindeman, Sweden
Add to calendar2021-05-27 14:00 2021-05-27 15:30 Europe/Madrid COVID-19 SYMPOSIUM Moderators: Evangelia Liakoni, Switzerland and Erik Lindeman, SwedenEAPCCT 2021

 
14:00-14:20 Impact of COVID on poisons centres - a European perspective
Davide Lonati, Pavia Poison Control Centre, Pavia, Italy
14:20-14:40 Impact of COVID-19 on poisons centers - a US perspective
Diane Calello, Rutgers New Jersey Medical School, USA
14:40-15:00 The impact of the first wave of COVID-19 on Poisons Centre (PC) activities in 4 European countries: a pilot study
Laura Hondebrink, Utrecht, Netherlands (2021- Abstract 303)
15:00-15:10 A networked approach to a SARS-COV-2 information hotline in the state of Florida - design, implementation and lessons learned
Alfred Aleguas, Tampa, Florida, USA (2021 -Abstract 304)
15:10-15:20 Virtual education and networking during COVID: the ACMT COVID-19 Webinar series
Paul Wax, ACMT, Phoenix, USA
15:20-15:30 Questions & Answers to the Oral Platform Session speakers

At the end of this session the audience should be able to:
  • Describe the effect of pandemic waves on Europe Health System and how the EAPCCT working-group is investigating the influence of the COVID-19 pandemic on the work of European Poison Control Centres (PCCs).
  • Describe the process of expanding the role of a regional poison center to provide a 24/7 public health hotline in response to the COVID-19 pandemic, as an information service as well as a critical component of surveillance and response.
  • Describe the opportunities for virtual toxicology education and networking during a pandemic.

Rest break and AUTHORS WITH POSTERS (Afternoon grouping)

THURSDAY 27th | 15:30-16:00

Add to calendar2021-05-27 15:30 2021-05-27 16:00 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Afternoon grouping) Rest break and AUTHORS WITH POSTERS (Afternoon grouping)EAPCCT 2021

COVID-19 SYMPOSIUM

THURSDAY 27th | 16:00-17:40

Moderators: Ana Ferrer Dufol, Spain and Paul Dargan, United Kingdom
Add to calendar2021-05-27 16:00 2021-05-27 17:40 Europe/Madrid COVID-19 SYMPOSIUM Moderators: Ana Ferrer Dufol, Spain and Paul Dargan, United KingdomEAPCCT 2021

 
16:00-16:20 Toxicity of drugs and "other treatments" - Toxicity of therapeutic drugs used for COVID: an overview of the drugs used to treat COVID
Caroline Samer, Geneva University Hospitals, Switzerland
16:20-16:40 Toxicity of drugs and "other treatments" - Use of non-recommended toxic treatments (toxic alcohols/cleaning products etc.
Craig Smollin, University of California, San Francisco, USA
16:40-17:00 Impact of COVID-19 on recreational drugs in Europe - an overview from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Isabelle Giraudon, EMCDDA, Lisbon, Portugal
17:00-17:20 Intentional poisoning cases reported to the National Poisons Information Centre during the initial lockdown phase of COVID-19 Public Health restrictions
Nicola Cassidy, Dublin, Ireland (2021 Abstract 305)
17:20-17:30 Recreational drug toxicity Emergency Department presentations during the initial months of the COVID-19 pandemic
Juan Ortega Pérez, Palma de Mallorca, Spain (2021- Abstract 306)
17:30-17:40 Questions & Answers to the Oral Platform Session speakers

At the end of this session the audience should be able to:
  • List the repurposed and new drugs used in the context of COVID19 and outline the available clinical data regarding their efficacy and safety for COVID19 prophylaxis and treatment
  • Describe the mechanism of toxicity and treatment of patients exposed to sodium chlorite.
  • To learn about the impact of COVID-19 on recreational drugs in Europe (including on market, use, harm and treatment) based on a 'Trendspotter analysis' of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

END OF DAY 2

THURSDAY 27th | 17:40 - 17:50

Hosts: Ana Ferrer Dufol, Spain and Paul Dargan, United Kingdom
Add to calendar2021-05-27 17:40 2021-05-26 17:50 Europe/Madrid UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP Hosts: Ana Ferrer Dufol, Spain and Paul Dargan, United KingdomEAPCCT 2021

DRUG FORMULATION AND ITS IMPORTANCE IN THE POISONED PATIENT

FRIDAY 28th | 09:00 - 10:30

Moderators: Davide Lonati, Italy and Anselm Wong, Australia
Add to calendar2021-05-28 09:00 2021-05-28 10:30 Europe/Madrid DRUG FORMULATION AND ITS IMPORTANCE IN THE POISONED PATIENT Moderators: Davide Lonati, Italy and Anselm Wong, Australia EAPCCT 2021

 
09:00-09:20 The impact of new drug formulations on the assessment of the poisoned patient
Andis Graudins, Monash Health, Melbourne, Australia
09:20-09:35 The pharmacology of pharmacobezoars
Lotte Hoegberg, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark
09:35-09:55 Management of pharmacobezoars
Soeren Boegevig, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark
09:55-10:10 Misuse of prescriptions medicines by routes other than the intended route of use
David Wood, Guy's and St Thomas' NHS Foundation Trust, London, UK
10:20-10:30 Questions & Answers to the Session

At the end of this session the audience should be able to:
  • Explain the pharmacokinetic and pharmacodynamic features of poisoning with various newer drug formulations that can influence the risk assessment and initial management of the poisoned patient.
  • Identify known physicochemical properties of pharmaceutical preparations prone to cause pharmacobezoar formation - the formation and degradation.
  • Describe ways to identify the formation of pharmacobezoars and possible treatment modalities in the poisoned patient where their formation is suspected or identified.
  • Understand the frequency of and methods by which prescription medicines can be used by routes other than the intended licenced route(s) of use.

Rest break and Authors with posters (Morning grouping)

FRIDAY 28th | 10:30-11:00

Add to calendar2021-05-28 10:30 2021-05-28 11:00 Europe/Madrid Rest break and Authors with posters (Morning grouping) Rest break and Authors with posters (Morning grouping) EAPCCT 2021

LOUIS ROCHE LECTURE

FRIDAY 28th | 11:00 - 12:00
Add to calendar2021-05-28 11:00 2021-05-28 12:00 Europe/Madrid LOUIS ROCHE LECTURE LOUIS ROCHE LECTUREEAPCCT 2021

 
11:00-11:15 Introduction and presentation of the Louis Roche Lecturer
Horst Thiermann, EAPCCT President
11:15-12:00 Improving the evaluation, management and outcome of cardiotoxicant-poisoned patients - still a challenge for clinical toxicologists
Bruno Mégarbane, Paris-Diderot University, France

At the end of this session the audience should be able to:
  • understand the contribution of the proposed different therapies in cardiotoxicant poisonings

Authors with posters (Lunchtime grouping)

FRIDAY 28th | 12:00 - 12:30
Add to calendar2021-05-28 12:00 2021-05-28 12:30 Europe/Madrid Authors with posters (Lunchtime grouping) Authors with posters (Lunchtime grouping)EAPCCT 2021

GENERAL ASSEMBLY

FRIDAY 28th | 13:00 - 14:15

Hosts: Horst Thiermann (EAPCCT President), Davide Lonati (EAPCCT General Secretary), Sergej Zakharov and Bruno Mégarbane (EAPCCT Treasurers)
Add to calendar2021-05-28 13:00 2021-05-28 14:15 Europe/Madrid GENERAL ASSEMBLY Hosts: Horst Thiermann (EAPCCT President), Davide Lonati (EAPCCT General Secretary), Sergej Zakharov and Bruno Mégarbane (EAPCCT Treasurers)EAPCCT 2021

TOXICOLOGY 2.0 SYMPOSIUM

FRIDAY 28th | 14:15 - 16:45

Moderators: Chris Yates, Spain and Mark Zammit, Malta

 
Add to calendar2021-05-28 14:15 2021-05-28 16:45 Europe/Madrid TOXICOLOGY 2.0 SYMPOSIUM Moderators: Chris Yates, Spain and Mark Zammit, Malta EAPCCT 2021

 
14:15-14:30 Games for dissemination of poison prevention education to the public
Yu-Hao Cheng, Taiwan National Poison Control Center, Taipei, Taiwan
14:30-14:45 Artificial intelligence in medicine and toxicology: current trends and outlook
Matjaž Kukar, University of Ljubljana, Slovenia
14:45-14:55 Using Artificial Intelligence to understand recreational drug usage and toxicity from internet forums
Michael Chary (2020- Abstract 098)
14:55-15:10 The role of data from drug user forums in determining recreational drug and NPS toxicity
Sage Wiener, SUNY Downstate Health Sciences University, New York, USA
15:10-15:25 Google metrics and twitter to monitor recreational drugs and NPS trends
Jean Marie Perrone, University of Pennsylvania , Philadelphia, USA
15:25-15:35 The geospatial and linguistic dynamics of conversations on Twitter about vaping
Michael Chary (2020 -Abstract 099)
15:35-15:50 Robotic wastewater analysis to understand community consumption of opioids, cocaine, NPS and methamphetamines
Claire Duvallet, Biobot Analytics, Boston, USA
15:50-16:05 Web monitoring tools to monitor trends in prescription medicine misuse
Rick Dart, Denver Health and Hospital Authority, Denver, USA
16:05-16:20 Ingestible Electronics and Robotic Systems to measure medication adherence and drug use events
Peter Chai, Brigham and Women's Hospital, Boston, USA
16:20-16:35 Telemedicine as an assessment tool in chemical weapon attacks, experience in Syria with global implications
Tim Erickson, Brigham Health / Harvard Medical School, Boston, USA
16:35-16:45 Questions & Answers to the Toxicology 2.0 speakers

At the end of this session the audience should be able to:
  • Identify important poisoning trends.
  • State the features of poisoning events in different age groups.
  • Describe the importance and challenges of poison prevention education.
  • List two effective strategies for delivering poison prevention knowledge to children.
  • Describe various modern artificial intelligence techniques, applicable in different scenarios and types of data (tabular data, images, text), as well as determine and decide which particular problems are suitable for application of AI techniques.
  • Explain the role of online drug information forums in both reflecting and driving patterns of drug use, and their utility and limitations in studying these patterns.
  • Describe tools in Google and Twitter that can help characterize novel psychoactive substance trends.
  • Explain the basic concepts behind using wastewater epidemiology to measure populationlevel exposure and consumption of opioids, cocaine, NPS and methamphetamines and describe results from a pilot study applying wastewater epidemiology to map opioid consumption in a US municipality
  • Understand the appropriate use of data derived from various types of social media.
  • Understand the current state of art in ingestible electronics and the principles of biosensing in drug testing.
  • Describe current use of telemedicine and other emerging technologies in the setting of chemical weapon attacks.

Rest break and Authors with posters (Afternoon grouping)

FRIDAY 28th | 16:45-17:15

Add to calendar2021-05-28 16:45 2021-05-28 17:15 Europe/Madrid Rest break and Authors with posters (Afternoon grouping) Rest break and Authors with posters (Afternoon grouping)EAPCCT 2021

END OF DAY 3, END OF EAPCCT 2021 VIRTUAL CONFERENCE

FRIDAY 28th | 17:50

Moderators: Horst Thiermann, Lotte Hoegberg Copenhagen, Denmark
Add to calendar2021-05-28 17:50 2021-05-28 18:00 Europe/Madrid END OF DAY 3, END OF EAPCCT 2021 VIRTUAL CONFERENCE Moderators: Horst Thiermann, Lotte Hoegberg Copenhagen, DenmarkEEAPCCT 2021

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

FRIDAY 28th | 17:15 - 17:50

Moderators: Thiermann, Munich, Germany and Lotte Hoegberg, Copenhagen, Denmark
Add to calendar2021-05-28 17:15 2021-05-28 17:50 Europe/Madrid ORAL PLATFORM AND SHORT ORAL PRESENTATIONS Moderators: Thiermann, Munich, Germany and Lotte Hoegberg, Copenhagen, Denmark EAPCCT 2021

 
17:15-17:25 Foodborne botulism: a large outbreak in Sicily
Azzurra Schicchi, Pavia, Italy (2021 Abstract 307)
17:25-17:45 Shiitake Dermatitis: a French nationwide study 2014-2019
David Boels, Nantes, France (2021- Abstract 308)
17:45-17:50 Questions & Answers to the Oral platform and Short Oral Presentation speakers

WELCOME DAY 3 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM

FRIDAY 28th08:45 - 09:00

Host: Alex Campbell, United Kingdom

Add to calendar2021-05-28 08:45 2021-05-28 09:00 Europe/Madrid WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM Host: Alex Campbell, United Kingdom EAPCCT 2021

REST BREAK / AUTHORS WITH POSTERS (MORNING GROUPING)

  • Morning Posters - Room 01
    116  Massive gamma-hydroxybutyric acid overdose resulting in severe metabolic acidosis requiring continuous venovenous haemofiltration
    Anselm Wong, Victorian Poisons Information Centre, Austin Toxicology and Emergency Department, Austin Health, Victoria, Australia.
    Drugs of abuse and NPS poisoning

    138  Just “https://eapcct2021.com/administrator/index.php#wf-editor-sourcenanging” around: case series of neurological sequelae from chronic nitrous oxide abuse
    Angela L Chiew, Clinical Toxicology Unit, Prince of Wales Hospital, Sydney, Australia.
    Drugs of abuse and NPS poisoning

    197  Analytically-confirmed exposure to new psychoactive substances in patients with severe clinical toxicity in the UK, 2015-2018: a report from the IONA study
    Simon H Thomas, Narional Poisons Information Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
    Drugs of abuse and NPS poisoning

    198  Increasing abuse and addiction to nitrous oxide (N2O): still a legal high in Denmark
    Lotte CG Hoegberg, Department of Anaesthesiology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
    Drugs of abuse and NPS poisoning

    309  Severe cardiac and neurological toxic effects due to synthetic cannabinoid cumyl-pegaclone (SGT-151) alone: a case report
    Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
    Drugs of abuse and NPS poisoning

    310  Beta-hydroxybutyrate closed the gap in a sober patient with high anion gap metabolic acidosis: a case report
    Marian Piqueur, Department of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
    Drugs of abuse and NPS poisoning

  • Morning Posters - Room 02
    117  Hyperemesis and acute kidney injury following a “rebirth” ceremony with kambô and iboga in the Netherlands
    Marian Piqueur, Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
    Drugs of abuse and NPS poisoning

    126  Clinical effects following the use of freely available herbal drugs: the toxicity of “Happy Caps”
    Antoinette JHP Riel, Dutch Poisons Information Center(DPIC), Univesity Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
    Drugs of abuse and NPS poisoning

    131  Recreational nitrous oxide use rises dramatically after change in EU legislation
    Antoinette JHP Van Riel, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht Univeristy, Utrecht, Netherlands.
    Drugs of abuse and NPS poisoning

    136
      Treating patients with opioid overdose at a primary care emergency outpatient clinic: a cost-minimization analysis
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    137
      Self-discharge during treatment for acute recreational drug toxicity: an analysis of four-years of Euro-DEN Plus presentations
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    150
      Treatment with naloxone and follow up after opioid overdose outside of hospital: observational data 2014-2018 in Oslo, Norway
    Arne K Skulberg, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway; Pre-hospital Division, Air Ambulance Department, Oslo University Hospital, Oslo, Norway ; The Norwegian Air Ambulance Foundation, Oslo, Norwa, Trondheim, Norway.
    Drugs of abuse and NPS poisoning

    158
      Change of quality of life in prescription opioid patients after rapid opioid detoxification
    Gabija Laubner, Republican Vilnius University Hospital, Centre of Toxicology; Vilnius University Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
    Drugs of abuse and NPS poisoning

    160
      First identification of synthetic cannabinoid 5F-MDMB-PICA in Italy
    Carlo Alessandro Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Drugs of abuse and NPS poisoning

    313
      Poisoning by central stimulant drugs in Oslo, Norway
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    314  Acute poisoning from concurrent use of opioids and amphetamine
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    315
      Acute recreational drug toxicity among young patients
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    316
      Acute poisonings involving cannabis in Oslo, Norway
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    317
      Psychosis associated with acute recreational drug toxicity
    Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning
  • Morning Posters - Room 03
    007  The severity and mortality prediction of calcium-channel blocker poisoning in the intensive care unit
    Chun Kuei Chen, Emergency department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
    Pharmaceutical Poisoning

    201
      Comparison of the Australian and New Zealand Referral Criteria versus the King’s College Criteria to predict mortality or liver transplant in paracetamol overdose
    Anselm Wong, Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Victoria, Australia.
    Pharmaceutical Poisoning

    241
      Angiotensin axis antagonists increase the severity of dihydropyridine poisoning
    Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
    Pharmaceutical Poisoning

    242
      A case series of flecainide poisoning
    Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
    Pharmaceutical Poisoning

    243
      Effect of serum alkalinisation on QRS narrowing in tricyclic antidepressant poisoning
    Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
    Pharmaceutical Poisoning

    244
      Optimal way to achieve serum alkalinisation in tricyclic antidepressant overdose
    Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hosptial, Sydney, Australia.
    Pharmaceutical Poisoning

    246
      An uncommon cause of high-anion gap metabolic acidosis after repeated supratherapeutic paracetamol ingestion
    Hwee Min D Lee, Emergency, Monash Health, Melbourne, Australia.
    Pharmaceutical Poisoning

    262
      Lurasidone mono-ingestion overdoses: a case series with minimal toxicity
    Andis Graudins, Clinical Toxicology Unit, Emergency Medicine Service, Monash Health and Monash University, Dandenong, Australia.
    Pharmaceutical Poisoning

    331
      A 1-year prospective analysis of propranolol exposures reported to the UK National Poisons Information Service (NPIS)
    Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
    Pharmaceutical Poisoning

    332
      Intravenous pentobarbital overdose treated with supportive care and multidose activated charcoal
    Rachel WC Ng, Clinical Pharmacology and Toxicology, Western Sydney Local Health District Toxicology Service, Westmead, Australia.
    Pharmaceutical Poisoning

    333
      The impact of codeine upscheduling on prescriptions, overdoses, Emergency Department presentations and mortality in Victoria, Australia
    Anselm Wong, Victorian Poisons Information Centre and Austin Toxicology Unit, Austin Health, Victoria, Australia.
    Pharmaceutical Poisoning
  • Morning Posters - Room 04
    196  Is fentanyl responsible for more severe neuro-respiratory depression than morphine? A rat in vivo investigation
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Mechanisms of Toxicity and Basic Research

    231  Sarolaner-poisoning in an infant: a case report
    Angelika Holzer, Poisons Information Centre Austria, Vienna, Austria.
    Pharmaceutical Poisoning

    252
      Acute kidney failure due to acetaminophen overdose: a case report
    Marian Piqueur, Departement of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
    Pharmaceutical Poisoning

    253
      Venlafaxine-associated hypoglycemia: frequency and correlation with symptom severity
    Elias Bekka, Department of Clinical Toxicology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
    Pharmaceutical Poisoning

    254
      Hydroxyzine poisoning in the intensive care unit: predictive factors of cardiovascular complications and toxicokinetics
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    255
      Lamotrigine poisoning in the ICU: a case series with evaluation of the toxicocokinetics and the predictive value of the plasma concentration on admission
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    256
      Rispiridone poisoning in the intensive care unit: evaluation of the poisoning severity on admission
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    257
      Nicardipine poisoning in the intensive care unit: management, outcome and toxicokinetics
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    258
      Poisonings involving angiotensin-converting enzyme inhibitors in the intensive care unit: a case series
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    259
      Salicylate poisoning admitted to the intensive care unit: features and toxicokinetics
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    260
      Antidepressant drug poisonings and the risk of thromboembolic complications: a case series from an intensive care unit
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Pharmaceutical Poisoning

    263  Combined beta-blocker and beta-agonist drugs overdose: an unusual balance
    Andrea Giampreti, Bergamo Poison Control Center, Papa Giovanni XXIII Hospital, BERGAMO, Italy.
    Pharmaceutical Poisoning

    264
      Characteristics of use and outcome of naloxone administration to non-intensive care and non-surgical hospitalized adult patients: a pilot study
    Ophir Lavon, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.
    Pharmaceutical Poisoning

    266
      Medication errors in nursing homes and other residential institutions with full-time staff attendance: a Danish Poisons Information Centre quality project
    Karen R Eriksen, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
    Pharmaceutical Poisoning

    268
      Crisis averted? Olanzapine as an antidote for serotonin toxicity: a case report
    Erik Lindeman, Swedish Poisons Informatiom Center, Stockholm, Sweden.
    Pharmaceutical Poisoning

    269
      Non-cardiogenic pulmonary edema in amlodipine poisoning: the lesser evil?
    Erik Lindeman, Swedish Poisons Information Center, Stockholm, Sweden.
    Pharmaceutical Poisoning

    271
      Pharmacobezoar and gastric perforation in severe quetiapine intoxication: a case report
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Pharmaceutical Poisoning

    273
      Intoxication with colchicine: a retrospective study
    Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Pharmaceutical Poisoning

    334
      Intravenous iron overdose: don’t trust the blood levels
    Ann-Charlott Svanhagen, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
    Pharmaceutical Poisoning
  • Morning Posters - Room 05
    011  Hydrofluoric acid exposure: a five-year review of enquiries made to the UK National Poisons Information Service (NPIS)
    Michael J Beech, NPIS (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
    Epidemiology of poisoning

    012  Enquiries to the National Poisons Information Centre in Ireland from ambulance control, emergency medical dispatchers and paramedics attending poisoning incidents from 2010-2018
    Edel Duggan, National Poisons Information Centre, Beaumont Hospital, Dublin, Ireland.
    Epidemiology of poisoning

    014  109 toxicological inquiries for one patient
    Daniela Pelclova, Toxicological Information Centre, First Medical Faculty and General University Hospital, Prague, Czech Republic.
    Epidemiology of poisoning

    019  Eye injuries: case reports to the BfR from 2004 to 2018
    Kathrin Begemann, Department Exposure, Federal Institute for Risk Assessment (BfR), Berlin, Germany.
    Epidemiology of poisoning

    020
      A worrying trend: Poisonings with pharmaceuticals in young girls in Norway
    Merethe Midtervoll, Norwegian Poison Information Centre, National Institute of Public Health, Oslo, Norway.
    Epidemiology of poisoning

    021  Study on e-liquids: risk of exposure and effectiveness of regulation by Tobacco Products Directive 2
    Nina Glaser, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
    Epidemiology of poisoning

    025  Mortality and patient characteristics in paracetamol overdosing: a retrospective study
    Soeren Boegevig, Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
    Epidemiology of poisoning

    106  Assessment of advice given by the Danish Poisons Information Centre concerning medication errors in nursing homes and institutions
    Soeren Boegevig, Department of Clinical Pharmacology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
    Epidemiology of poisoning

    108
      Utilization of the Danish Poisons Information Centre: a nationwide registry study
    Tonny S Petersen, Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark.
    Miscellaneous
  • Morning Posters - Room 06
    077  Beauty can occasionally be toxic: local irritation from a houseplant
    Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Plant and Mushroom Poisoning

    087  Kombucha tea: a potential hepatotoxic agent
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Plant and Mushroom Poisoning

    348  Veratrum Aqua poisonings resulting from its misuse: a case series from Moscow, Russia
    Elizaveta V Melnik, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
    Plant and Mushroom Poisoning
  • Morning Posters - Room 07
    046  Unanticipated sources of methanol poisoning: report of two cases
    Jones CM Chan, Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong.
    Household Products Poisoning

    049
      Laundry pod exposure in children: evaluation of 17 years’ of cases in a tertiary care hospital in Italy
    Marcello Montibeller, Department of Emergency. Regional Paediatric Control Center., Bambino Gesù Children's Hospital, Rome, Italy.
    Household Products Poisoning

    351
      Protective effects of hypercalcaemia in the setting of severe hypermagnesaemia
    David Emmerig, Western Sydney Local Health District Toxicology Service, Western Sydney Local Health District Toxicology Service, Westmead, Australia.
    Household Products Poisoning

    352
      Caustic exposures attending the Emergency Department: results of the Spanish Toxic Surveillance System (STSS) 2010-2019
    Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
    Household Products Poisoning
  • Morning Posters - Room 08
    036  Assessment of the effectiveness of gastric lavage in organophosphorus poisoning by quantifying pesticide in lavage fluid
    Indira Madhavan, General Medicine, Associate Proferssor, Thrissur, India.
    Pesticide Poisoning

    042
      Human exposures to pesticides: results of a subproject of the German pilot study PiMont
    Esther Feistkorn, German Federal Institute for Risk Assessment, Department Exposure, Unit Exposure Assessment of Hazardous Products, Berlin, Germany.
    Pesticide Poisoning

    358
      Hepatorenal dysfunction following fipronil ingestion
    Indira Madhavan, Government Medical College, Thrissur, India.
    Pesticide Poisoning

    359
      Malathion poisoning causing prolonged cholinergic crisis and refractory hypotension requiring high-dose atropine treatment
    Kit Rowe, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
    (only available on May 27th)
    Pesticide Poisoning
  • Morning Posters - Room 09
    002  A watchful foretaste of Article 45 Annex VIII: things you will wish you knew before
    Geert Verstegen, Belgian Poison Centre, Brussels, Belgium.
    Miscellaneous

    003
      Current experience of the Belgian Poison Centre with the new product notification requirements implementing article 45
    Anne-Marie K Descamps, Belgian Poison Centre, Brussels, Belgium.
    Miscellaneous

    179
      Human skin explants ex vivo study: lesions caused by topical exposure to 25% tetramethylammonium hydroxide (TMAH)
    Alan H Hall, Medical Toxicology, Toxicology Consulting and Medical Translating Services, Azle, Texas, United States.
    Miscellaneous

    190
      Risk assessment and lessons learned: a collaboration between Public Health and a National Poisons Information Centre
    Edel Duggan, National Poisons Information Centre, Dublin, Ireland.
    Miscellaneous

    204
      Bedside formate analysis in methanol poisoned patients: a pilot study
    Knut Erik Hovda, The National CBRNE Centre of Medicine, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
    Analytical and Forensic Toxicology - including bedside testing

    205
      Bedside quantitative electroencephalographic monitoring using the Patient State Index correlates poorly with Glasgow Coma Score in acutely poisoned patients
    Shaun L Greene, Victoria Poisons Information Centre, Austin health, Melbourne, Australia.
    Pharmaceutical Poisoning

    207
      A one-year retrospective study of caustic injury in adults admitted to a toxicology department
    Julia V Radenkova-Saeva, Clinic of Toxicology, UMHATEM "N.I.Pirogov", Sofia, Bulgaria.
    Caustic ingestion

    210
      False positive result on colorimetric methanol screening test: report of two cases with hyperglycaemia
    Jones CM Chan, Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong.
    Analytical and Forensic Toxicology - including bedside testing
  • Morning Posters - Room 10
    057  Alcohol "abuse" among children younger 5 years
    Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Paediatric Poisoning

    060
      Overrepresentation of flavoured, orodispersible tablets in paediatric paracetamol overdoses
    Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
    Paediatric Poisoning

    061
      Drug-induced liver injury induced by nicotinamide
    Maren Hermanns-Clausen, Poisons Information Centre, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center – University of Freiburg, Freiburg, Germany.
    Paediatric Poisoning

    064
      Pediatric and adolescent self-poisoning: a 3-year case series
    Carlo Alessandro Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Paediatric Poisoning

    202
      Three years of experience implementing a chemical submission protocol at an Emergency Department
    Juan Ortega Pérez, Emergengy Department Hospital Universitari Son Espases, Attending Physician, Palma de Mallorca, Spain.
    Miscellaneous

    367
      The importance of free digoxin serum concentrations: case report of an infant treated for digoxin poisoning
    Marco Marano, Pediatric Intensive Care Unit; Pediatric Poison Control Center, Children's Hospital Bambino Gesù, Rome, Italy.
    Paediatric Poisoning

    368
      Fentanyl transdermal patch mistaken for wound patch: two pediatric case reports
    Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
    Paediatric Poisoning

    369
      Bottles and messages revisited: circumstances of poisonings among infants under 1 year old in Estonia
    Ruth Kastanje, Poisonings Information Centre, Estonian Health Board, Tallinn, Estonia.
    Paediatric Poisoning

    370
      Alcohol abuse among teenagers during the vacation period: description and pattern differences by gender
    Juan Ortega Pérez, Adult emergency department. Toxicology Unit, Attending physician, Palma de Mallorca, Spain.
    Paediatric Poisoning

    372
      Paediatric paracetamol overdose: reducing side-effects with the SNAP 12 hour N-acetylcysteine regime
    David G Cairney, Acute Receiving Unit, Royal Hospital for Sick Children, Edinburgh, United Kingdom.
    Paediatric Poisoning
  • Morning Posters - Room 11
    195  Antidote treatment in viper envenomation in Italy: a comparison of 4 antivenoms during a 6 year study
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Toxinology (bites, stings, antivenom etc)

    278  The changing pattern of treatment for latrodectism over time in a toxicology unit: red-back spider antivenom or standard analgesic therapy: nothing to RAVE about
    Andis Graudins, Clinical Toxicology Unit, Emergency Medicine Service, Monash Health and Monash University, Dandenong, Australia.
    Toxinology (bites, stings, antivenom etc)

    280  A serious viper bite in a pregnancy
    Francesco Gambassi, Toxicology Unit and Poison Control Center, Firenze, Italy.
    Toxinology (bites, stings, antivenom etc)

    281  Spider bites in France: a retrospective study using the French Poison Control Centers Network from 2007 to 2017
    Gaël Le Roux, Centre antipoison et Toxicovigilance Grand Ouest, Centre antipoison et Toxicovigilance Grand Ouest, Angers, France.
    Toxinology (bites, stings, antivenom etc)

    283  Recurrent thrombocytopenia after Italian viper bite: a case report
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy, Pavia, Italy.
    Toxinology (bites, stings, antivenom etc)

    377  Hyperbaric oxygen therapy in Loxoscelism skin necrosis: a case report
    Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
    Toxinology (bites, stings, antivenom etc)

    378  Exotic venomous snakebites in Switzerland reported to the National Poisons Information Centre over 22 years
    Joan Fuchs, Tox Info Suisse, University of Zurich, Zurich, Switzerland.
    Toxinology (bites, stings, antivenom etc)

    379  Far from home: compartmental syndrome after envenomation by Crotalus atrox in metropolitan France
    Gaël Le Roux, Poison Control Center and Toxicovigilance, Angers, France.
    Toxinology (bites, stings, antivenom etc)

    380  Human exposure to larvae of processionary moths in France: study of symptomatic cases registered by the French Poison Control Centres between 2012 and 2019
    Sandra Sinno-Tellier, Health Alerts and Vigilance Department, French Agency for Food, environmental and Occupational Health & Safety, Maisons-Alfort, France.
    Toxinology (bites, stings, antivenom etc)

AUTHORS WITH POSTERS (LUNCHTIME GROUPING)

  • Lunchtime Posters - Room 01
    119  3,4-Methylenedioxy-α-pyrrolidinohexiophenone (MDPHP): four severe confirmed intoxicationsn
    Dieter Müller, Clinical Toxicology Laboratory, GIZ-Nord Poisons Centre, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
    Drugs of abuse and NPS poisoning

    143 Methadone poisonings admitted to the ICU: investigation of the predictive value of plasma methadone concentration and the required naloxone dose regimen
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Drugs of abuse and NPS poisoning

    147  Severe acidosis and prolonged coma after a massive overdose of gamma-hydroxybutyrate (GHB)
    Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
    Drugs of abuse and NPS poisoning

    155  The development of poisonings with illegal substances: data from the Danish Poisons Information Centre (DPIC)
    Dorte F Palmqvist, Department of Anaesthesiology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
    Drugs of abuse and NPS poisoning

    318  E-liquid sold as CBD e-liquid containing XRL-11: 4 cases reported. A warning signal to health authorities and e-cigarettes users
    Francis Grossenbacher, University Hospital Reims, Clinical Toxicologist Emergency Department, Reims, France.
    Drugs of abuse and NPS poisoning

    319  Significant cannabidiol (CBD) urine concentration in a young male admitted after using an e-cigarette obtained from a street market
    Francis Grossenbacher, University Hospital Reims, Clinical Toxicologist Emergency Department, Reims, France.
    Drugs of abuse and NPS poisoning

    320  Swedes like their O-juice from Florida and their E-juice from California
    Sonny Larsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
    Drugs of abuse and NPS poisoning

    321  Hydroxyphencyclidines (OH-PCPs), fluoroamphetamine (FA) and fluoromethamphetamine (FMA): an explosive NPS mixture and a challenge for appropriate sedation in a severely intoxicated patient patient.
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Drugs of abuse and NPS poisoning

    322  Recreational, inhalational misuse of hyoscine butylbromide (Buscopan®) tablets as reported to the UK National Poisons Information Service
    Emma J Moyns, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
    Drugs of abuse and NPS poisoning

    323  A case of crack-lung-like syndrome due to new synthetic opioid consumption with analytical confirmation
    Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre – Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
    Drugs of abuse and NPS poisoning

  • Lunchtime Posters - Room 02
    124  In-patient prescription opioid detoxification: peculiarities of consumption and treatment outcomes
    Gabija Laubner, Vilnius University, Faculty of Medicine, Vilnius, Lithuania, Vilnius University Emergency hospital, Vilnius, Lithuania.
    Drugs of abuse and NPS poisoning

    125 In-patient prescription opioid detoxification: gender differences and harmful habits
    Gabija Laubner, Vilnius University, Faculty of Medicine, Vilnius, Lithuania, Vilnius University Emergency hospital, Vilnius, Lithuania.
    Drugs of abuse and NPS poisoning

    132  Analysis of drugs in blood and urine samples from suspected spiked drink victims
    Odd Martin Vallersnes, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    142  Transient delayed brain edema after consumption of synthetic cathinones
    Sabrina Schmoll, Department for clinical toxicology and poision control centre munich, Klinikum rechts der Isar München, München, Germany.
    Drugs of abuse and NPS poisoning

    149   GHB overdose in nightlife settings and effectiveness of on-site harm-reduction organization
    Miran Brvar, Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
    Drugs of abuse and NPS poisoning

    152   Acute intoxication with α-pyrrolidinohexanophenone, 4-fluoromethylphenidate and aminopropylbenzofuran complicated with rhabdomyolysis: a case report
    Gambassi Francesco, Toxicology Unit and Poison Control Center, Careggi University Hospital, Florence, Italy.
    Drugs of abuse and NPS poisoning

    157  Characteristics of ecstasy toxicity in a Norwegian cohort of hospitalized poisoned patients
    Per Sverre Persett, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
    Drugs of abuse and NPS poisoning

    324 A comparative analysis between acute ethanol poisoning and acute ethanol combined with drugs of abuse poisoning in adolescents
    Viorela Nitescu, Pediatric Poisoning Centre Emergency Clinical Hospital for Children "Grigore Alexandrescu", Bucharest, Romania.
    Drugs of abuse and NPS poisoning

    325  Predicting hypertension using subjective symptoms in recreational drug users at first-aid stations at dance events
    Yoram P Prins, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, Netherlands.
    Drugs of abuse and NPS poisoning

  • Lunchtime Posters - Room 03
    335   Favorable acute toxicity profile of the “hiking” stimulant nikethamide
    Colette Degrandi, National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
    Pharmaceutical Poisoning

    336 Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis
    Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
    Pharmaceutical Poisoning

    337  “Reversal” of dabigatran-induced anticoagulation with idarucizumab: experience of an Italian hospital
    Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
    Pharmaceutical Poisoning

    338  Metformin-related enquiries from hospitals to the National Poisons Information Service (NPIS) between 2010-2019: a comparison of metformin only and polypharmacy exposures
    Bethan W Hughes, National Poisons Information Service, Cardiff, United Kingdom.
    Pharmaceutical Poisoning

    339  Characteristics of emergency department presentations following a drug suicide attempt
    Mirjam Kummer, Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
    Pharmaceutical Poisoning

    340  Propylthiouracil administration in 5 cases of thyroid hormone intoxication
    Francesca Maida, Pavia Poison Control Centre - National Toxicology Information Centre - Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Pharmaceutical Poisoning

    341  Evaluation of the overdosage section in Summaries of the Product Characteristics for medicines responsible for exposure calls to the Belgian Poison Centre
    Jonas Moens, Belgian Poison Control Centre, Neder-Over-Heembeek, Belgium.
    Pharmaceutical Poisoning

    342 Is haem arginate safer in overdose than previously thought? An uneventful four-fold accidental overdose
    Nandesh C Patel, National Poisons Information Service (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
    Pharmaceutical Poisoning

  • Lunchtime Posters - Room 04
    065  Animal PoisonLine: review of a new public access veterinary poisons information service
    Zoe Tizzard, Veterinary Poisons Information Service, London, United Kingdom.
    Veterinary toxicology (poisoning in animals)

    066 Flurbiprofen toxicosis in dogs
    Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
    Veterinary toxicology (poisoning in animals)

    067  A retrospective study of cement exposure in 42 dogs
    Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
    Veterinary toxicology (poisoning in animals)

    068  Cases of botulism in waterfowls in the Po river valley
    Carlo A. Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre, Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Veterinary toxicology (poisoning in animals)

    383  Role of decontamination in dogs poisoned by alphachloralose-based rodenticides: a case series
    Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
    Veterinary toxicology (poisoning in animals)

    384  “Curiosity killed the cat”: cats poisoned by alphachloralose containing rodenticides
    Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
    Veterinary toxicology (poisoning in animals)

    385  A case series of hypothermic, sedated cats with sensory-induced CNS excitation: alphachloralose poisoning?
    Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
    Veterinary toxicology (poisoning in animals)

    386 When does xylitol-induced hypoglycaemia occur in dogs?
    Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
    Veterinary toxicology (poisoning in animals)

    387 The effect of the COVID-19 pandemic on call numbers to the Veterinary Poisons Information Service (VPIS) and Animal PoisonLine (APL)
    Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
    Veterinary toxicology (poisoning in animals)

    388 The effect of the COVID-19 pandemic on animal poisons cases reported to the Veterinary Poisons Information Service (VPIS) and Animal PoisonLine (APL)
    Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
    Veterinary toxicology (poisoning in animals)

    389 The successful treatment of thallium sulfate toxicity in a dog using Prussian blue
    Anne Kan, Dutch Poisons Information Center, University Medical Center, Utrecht, Netherlands.
    Veterinary toxicology (poisoning in animals)

  • Lunchtime Posters - Room 05
    005  Is lithium exposure responsible for brain injuries with prolonged treatment or? A rat investigation
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Mechanisms of Toxicity and Basic Research

    009 Flurbiprofen toxicosis in dogs
    Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
    Epidemiology of poisoning

    010 An analysis of cases of methaemoglobinaemia reported in telephone enquiries to the UK’s National Poisons Information Service (NPIS)
    Victoria A Eagling, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
    Epidemiology of poisoning

    017   Drug-induced death in the intensive care unit in France: what are the characteristics?
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Epidemiology of poisoning

    023  Review of drug poisoning assessment at Emergency Department
    Marieke A Dijkman, Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Epidemiology of poisoning

    100  Poisoning in adolescents
    Patricia Casey, National Poisons Information Centre of Ireland, Dublin, Ireland.
    Epidemiology of poisoning

    115 The ICU Requirement Score (IRS) - does it identify poisoned patients who do not need intensive care unit referral? A validation cohort study
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    VEpidemiology of poisoning

    344  Comparison of acute kidney injury and renal replacement therapy in patients with rhabdomyolysis acutely intoxicated with psychotropic or chemical substances
    Aleksandra Babulovska, Toxicology, University Clinic of Toxicology, Skopje, Macedonia.
    (only available on May 27th)
    Epidemiology of poisoning

    345 Increasing enquiries to the Norwegian Poison Information Center (NPIC) concerning ozone
    Marte S Evje, Norwegian Institute of Public Health, Norwegian Poison Information Centre, Oslo, Norway.
    Epidemiology of poisoning

    346 A 10-year review of ocular exposures reported to the Irish National Poisons Information Centre
    Conor P Malone, National Health Library and Knowledge Service, HSE, Dublin, Ireland.
    Epidemiology of poisoning

    347 Fatalities due to acute poisoning: a one year retrospective study
    Julia V Radenkova - Saeva, Clinic of Toxicology, University Hospital for Emergency Medicine „ N.I.Pirogov”, Sofia, Bulgaria.
    Epidemiology of poisoning

  • Lunchtime Posters - Room 06
    071   A 16 year (2002-2017) review of enquiries regarding plant abuse in Austria
    Susanna Dorner-Schulmeister, Poisons Information Centre Austria, Vienna, Austria.
    Plant and Mushroom Poisoning

    072  A 16-year (2002-2017) review of suicide attempts by plant ingestion in Austria
    Susanna Dorner-Schulmeister, Poisons Information Centre Austria, Vienna, Austria.
    Plant and Mushroom Poisoning

    091  Mistaking monkshood for radish resulting in a potentially fatal blood concentration of aconitine
    Uwe Stedtler, Faculty of Medicine, Medical Centre, University of Freiburg, Freiburg, Germany.
    Plant and Mushroom Poisoning

    092   Intoxication with castor beans
    Marine Grigoryan, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Plant and Mushroom Poisoning

    112  Mushroom poisonings in Finland: a 15-year retrospective study
    Anne Tähkäpää, Poison Information Center, University of Helsinki and Department of Emergency Medicine and Services, Helsinki, Finland.
    Epidemiology of poisoning

    349  Lethal poisoning with Oenanthe crocata. Survive or not?
    Marieke A Dijkman, Alexis Descatha, PCC, Ester Unit (IRSET U1085), Univ Angers- CHU Angers- Inserm, Angers, France.
    Plant and Mushroom Poisoning

  • Lunchtime Posters - Room 07
    219  Clozapine-induced anemia: a case report
    Andrea Giampreti, Emergency care, Poison Control Center, Bergamo, Italy.
    Adverse reactions from medications

    220 Lacosamide-induced recurrent ventricular fibrillation
    Andrea Giampreti, Emergency care, Poison Control Center, Bergamo, Italy.
    Adverse reactions from medications

    222 Bleeding events due to warfarin therapy: how much does it cost?
    Gabija Laubner, Toxicology Centre, Republican Vilnius University Hospital, Centre of Toxicology, Vilnius, Lithuania.
    Adverse reactions from medications

    223   Phenytoin intoxication associated with omeprazole administration in a child with CYP2C9 polymorphism
    Marco Marano, Emergency Department PICU. Regional Pediatric Poison Control Center., Bambino Gesù Children Hospital, Rome, Italy.
    Adverse reactions from medications

    226   Olanzapine overdose-induced agranulocytosis
    Gordana Vukovic Ercegovic, Department of Clinical Toxicology, National Poison Control Center, Military Medical Academy, Belgrade, Serbia.
    (only available on May 27th)
    Adverse reactions from medications

    227   From kitchen to clinical use, to emergency department admission: an Italian story about curcumin
    Francesco Gambassi, Toxicology Unit, Poison Control Center of Careggi University Hospital, Florence, Italy.
    Adverse reactions from medications

    229  Bowel perforation due to methotrexate therapeutic error: a case report.
    Francesco Gambassi, Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Adverse reactions from medications

    390  Pharmacovigilance for identification and prevention of therapeutic errors
    Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
    Adverse reactions from medications

    391  Lamotrigine-induced Stevens-Johnson syndrome: a case report
    Andrea Giampreti, Emergency Department, Poison Control Center, Bergamo, Italy.
    Adverse reactions from medications

    392  Dimethyl fumarate-induced hepatotoxicity confirmed by biopsy
    Ophir Lavon, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.
    Adverse reactions from medications

  • Lunchtime Posters - Room 08
    001   Effect of ethanol coingestion in patients with central nervous system (CNS)-depressant intoxication
    Eva-Carina Heier, Division of Clinical Toxicology and Poison Control Centre Munich, Department of Internal Medicine II, TUM School of Medicine, Technical University of Munich, Munich, Germany.
    Alcohol as a co-ingestant

    031  Adults admitted to the emergency department of a university hospital in Belgium for acute poisoning with ethanol as a co-ingestant: characteristics and direct medical costs
    Anne-Marie K Descamps, Belgian Poison Centre, Brussels, Belgium.
    Alcohol as a co-ingestant

    175 EXP3OP study: occupational eye exposures reported to a western France poison center
    Gaël Le Roux, Centre antipoison et Toxicovigilance Grand Ouest, CHU d'Angers, Angers, France.
    Occupational poisoning

    399  Severe gasoline poisoning and its treatment. The autonomy of the lung response facing different pathogenic agents
    Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
    Occupational poisoning

    400  The health and blood aluminium concentration in firefighters following the Alytus tyre recycling factory fire
    Gabija Laubner, Toxicology center, Republic Vilnius university hospital, Vilnius, Lithuania.
    Occupational poisoning

    401  A case of acute occupational exposure to sodium molybdate with determination of molybdenum concentration
    Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Occupational poisoning

  • Lunchtime Posters - Room 09
    178  The role of CYP450 in the molecular toxicology of sulfur mustard in vitro
    Presented By Simone Rothmiller, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
    Miscellaneous

    181  “All right, I’ll be more careful next time”: frequent callers in Finnish Poison Information Centre (FPIC)
    Suvi Pajarre-Sorsa, Poison Information Centre, Poison Information Centre, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland.
    Miscellaneous

    184  Risky dietary supplements: self-harm with potassium salt capsules
    Sonny Larsson, Swedish Poison Information Centre, Solna, Sweden.
    Miscellaneous

    188  Supporting the establishment of an Ethiopian Poisons Centre
    Ruben Thanacoody, National Poisons Information Service (Newcastle Unit), Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
    Miscellaneous

    192  Diphtheria: two cases treated with antitoxin
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Miscellaneous

    363   Requests regarding snus to the Poisons Information Centre in Austria
    Tara Arif, Poisons Information Centre, Vienna, Austria.
    Miscellaneous

    364   Multiple treatments of clotrimazole during pregnancy
    Sian C D Harbon, National Poisons Information Service, Cardiff, United Kingdom.
    Miscellaneous

    365 Challenges facing the UK National Poisons Information Service (NPIS) ahead of EU Exit and commencement of Annex VIII of Article 45 (Classification, Labelling and Packaging)
    Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
    Miscellaneous

    366   When volvulus hides a poisoning: a case of severe foodborne botulism
    Roberto Zoppellari, Department of Anaesthesia and Intensive Care, S. Anna Hospital, Ferrara, Italy.
    Miscellaneous

REST BREAK AND AUTHORS WITH POSTERS(AFTERNOON GROUPING)

  • AFTERNOON Posters - Room 01
    109   Non-medical use and injection use of prescription opioids in Europe in the Non-Medical Use of Prescription Drug (NMURx) National Surveys
    Janetta L Iwanicki, Rocky Mountain Poison and Drug Safety, Denver, United States.
    Drugs of abuse and NPS poisoning

    118 Drug abuse trends, focussing on novel psychoactive substances (NPS) over the last three years (2016-2018) from the perspective of the Austrian Poisons Information Centre
    Kinga Bartecka-Mino, Poisons Information Centre Austria, Vienna, Austria.
    Drugs of abuse and NPS poisoning

    122  A retrospective study of observation times in a healthcare facility and 48-hour mortality after heroin overdose with naloxone rescue
    William Rushton, Office of Medical Toxicology, Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, United States.
    Drugs of abuse and NPS poisoning

    127  Analysis of Twitter content to explore use of modafinil and methylphenidate as drugs to facilitate studying in the UK
    David Wood, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
    Drugs of abuse and NPS poisoning

    128  Non-medical use of prescription and over the counter opioids in the UK
    David Wood, Clinical Toxicology, Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom.
    Drugs of abuse and NPS poisoning

    140  Significant cannabidiol (CBD) urine concentration in a young male admitted after using an e-cigarette obtained from a street market
    Alison M Dines, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, United Kingdom.
    Drugs of abuse and NPS poisoning

    145  Mining and analysis of opioid content in longitudinal data posted in a social media forum
    Jeanmarie Perrone, Emergency Medicine, University of Pennsylvania, Philadelphia, United States.
    (only available on May 28th)
    Drugs of abuse and NPS poisoning

    156  Hydroxyphencyclidines (OH-PCPs), fluoroamphetamine (FA) and fluoromethamphetamine (FMA): an explosive NPS mixture and a challenge for appropriate sedation in a severely intoxicated patient patient.
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Drugs of abuse and NPS poisoning

    326  Acute recreational drug toxicity in Ghent, Belgium. Comparison of self-reports and analytical detection by immunoassay (IA) and mass spectrometry (MS) testing
    Laurence Daveloose, Emergency medicine, UZ Ghent, Ghent, Belgium.
    Drugs of abuse and NPS poisoning

    327  In vino veritas: accidental MDMA poisoning by illicit drug trafficking
    Katrin Faber, National Poisons Information Centre, Associated Institute of the University of Zurich, Zurich, Switzerland.
    Drugs of abuse and NPS poisoning

    328  Frequent hospitalization for synthetic cathinone poisonings: a case series reported to the Dutch Poisons Information Center
    Johanna J Nugteren-Van Lonkhuyzen, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, Netherlands.
    Drugs of abuse and NPS poisoning

    329  Exposures involving opioids and alcohol reported to the US Poison Centers
    Saumitra Rege, Department of Emergency Medicine, University of Virginia, Charlottesville, United States.
    Drugs of abuse and NPS poisoning

    330  The Color Purple: death associated with brorphine, an emerging novel synthetic opioid
    Varun Vohra, Emergency Medicine, Michigan Poison Center, Wayne State University School of Medicine, Detroit, United States.
    Drugs of abuse and NPS poisoning

  • AFTERNOON Posters - Room 02
    402  Acute poisoning in Moscow during COVID-19 restrictive measures
    Anastasia Yu Simonova, Toxicological department, N.V. Sklifosovsky’ Research Institute of Emergency Medicine, Moscow, Russian Federation.
    Covid-19 and toxicology

    403 Unintended consequences of public health measures: exposures to alcohol-based hand sanitisers during the COVID-19 pandemic 2020
    Patricia Casey, National Poisons Information Centre of Ireland, Dublin, Ireland.
    Covid-19 and toxicology

    404  Increased exposures to alcohol-based hand sanitizers reported by an Italian Poison Center during the COVID-19 pandemic
    Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
    Covid-19 and toxicology

    405  Pediatric eye injuries related to public location of alcohol-based hand sanitizers during the first pandemic COVID-19 context: French Poison Control Centers data
    Alexis Descatha, PCC, Ester Unit (IRSET U1085), UNIV Angers, CHU Angers, Univ Rennes, Inserm, EHESP, Irset,, Angers, France.
    Covid-19 and toxicology

    406  Has the COVID-19 pandemic changed the pattern of poisoning cases attending Emergency Departments?
    Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
    Covid-19 and toxicology

    407  The only thing we have to fear is fear itself: inadvertent disopyramide toxicity during the COVID-19 pandemic
    Emma R Furlano, Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, New York, United States.
    Covid-19 and toxicology

    408  Nicotine does not affect SARS-CoV-2 in-host viral kinetics in a modeling and simulation study
    Charlotte Kern, Department of General Internal Medicine, Clinical Pharmacology and Toxicology, Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern; Graduate School for Health Sciences, University of Bern, Bern, Bern, Switzerland.
    Covid-19 and toxicology

    409  A human exposure to chlorine dioxide solution...not the solution
    Valle Molina, Emergencie, Complejo Hospitalario de Navarra, pamplona, Spain.
    Covid-19 and toxicology

    410  Changes in the epidemiological profile of poisonings during COVID-19: differences between the first half of 2019 and 2020
    Zanina Pereska, University Clinic of Toxicology, Skopje, Macedonia.
    (only available on May 27th)
    Covid-19 and toxicology

    411  Multiple factors in a COVID-19 patient leading to an elevated 5-oxoproline as cause of high-anion gap metabolic acidosis: a case report
    Marian Piqueur, Departement of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
    Covid-19 and toxicology

  • AFTERNOON Posters - Room 03
    200  Efficacy of a 12h intravenous acetylcysteine (SNAP) regimen following single acute paracetamol overdose
    Ruben HK Thanacoody, National Poisons Information Service (Newcastle), Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
    Pharmaceutical Poisoning

    239 Torsade de pointes following repeated massive loperamide ingestion
    Aza Kader, Swedish Poisons Information Centre, Stockholm, Sweden.
    Covid-19 and toxicology

    247  Using “symptom search” to resolve an unusual case of poisoning reported to the UK National Poisons Information Service (NPIS)
    Ho MR Lee, NPIS (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
    Pharmaceutical Poisoning

    249  Different courses of quetiapine poisoning in two patients with gastric decontamination
    Anne Stuerzebecher, Poisons Information Centre Erfurt, Erfurt, Germany.
    Pharmaceutical Poisoning

    261  Massive polypharmacy overdose resulting in diltiazem pharmacobezoar formation
    David Goldberger, Emergency Medicine, Albert Einstein Medical Center, Philadelphia, United States.
    Pharmaceutical Poisoning

  • AFTERNOON Posters - Room 04
    232  General characteristics of acute poisonings by hypotensive and antiarrhythmic drugs in Moscow, 2010-2017
    Presented By Anastasia Yu Simonova, Moscow N.V.SklifosovskyResearch Institute of emergency medical Help, Poisonng teatment Center, Moscow, Russian Federation.
    Pharmaceutical Poisoning

    233 Acute toxicity profile of levomepromazine in overdose: a consecutive case series
    Stefan Weiler, National Poisons Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
    Pharmaceutical Poisoning

    234  Be(a)ware of the fentanyl patch: unusual accidental cases of fentanyl intoxication
    Marianne EC Leenders, National Poisons Information Center/Department of Anesthesiology, University Medical Center, Utrecht, Netherlands.
    Pharmaceutical Poisoning

    235  Calls to the Finnish Poison Information Centre related to drug poisoning in older people
    Mervi Saukkonen, Poison Information Center, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.
    Pharmaceutical Poisoning

    236  Preliminary experience with plasmapheresis instead of molecular adsorbent recirculating system as liver support for paracetamol-induced hepatic failure
    Philippe Hantson, Intensive Care, Cliniques St-Luc, Université catholique de Louvain, Brussels, Belgium.
    Pharmaceutical Poisoning

    237 Acute poisoning with antihypertensive drugs: a retrospective study
    Julia V Radenkova-Saeva, Clinic of Toxicology,, UMHATEM “N.I.Pirogov”, Sofia, Bulgaria.
    Pharmaceutical Poisoning

    238  Rectal overdose of paracetamol
    Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
    Pharmaceutical Poisoning

    248  Favorable toxicity profile of escitalopram in acute overdose in adults
    Katharina M Schenk-Jaeger, National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
    Pharmaceutical Poisoning

    250  The association between phenytoin (diphenylhydantoin) and permanent cerebellar damage
    Rachel Day, National Poisons Information Service, Birmingham Centre, Birmingham, United Kingdom.
    Pharmaceutical Poisoning

    343  Literature review of antidotal carbapenem use in valproic acid toxicity
    William Rushton, Alabama Poison Information Center, Children's of Alabama, Birmingham, United States.
    Pharmaceutical Poisoning

  • AFTERNOON Posters - Room 05
    103 Mass acute thallium poisoning treated with enteral detoxification using Prussian blue and gut lavage
    Anastasyja Yu Simonova, N.V.Sklifosovsky Rtesearch Institute of Emergency Medicine, Poisonings Treatment Department, Moscow, Russian Federation..
    Heavy Metal Poisoning

    162 Arsenic exposure and peripheral neuropathy
    Chay J Markham, Cardiff University, Cardiff, United Kingdom.
    Heavy Metal Poisoning

    163 Gadolinum contrast media: old substance, new challenges
    Gabija Mikuleviciene, Toxicology Centre, Republican Vilnius University Hospital, Centre of Toxicology, Vilnius, Lithuania
    Heavy Metal Poisoning

    165 Comparison of unithiol (DMPS) treatment effect in two patients with severe cobalt intoxication
    Daniela Pelclova, Toxicological Information Centre, First Medical Faculty and General University Hospital, Prague, Czech Republic.
    Heavy Metal Poisoning

    168 Toxicokinetics of silver and chelation unithiol (DMPS) challenge tests in argyria due to colloidal silver
    Gasper Razinger, Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
    PHeavy Metal Poisoning

    412 An unsolved mystery: idiopathic thallium exposure resulting in clinically significant toxic effects
    Varun Vohra, Emergency Medicine, Michigan Poison Center at Wayne State University School of Medicine, Detroit, United States.
    Heavy Metal Poisoning


  • AFTERNOON Posters - Room 06
    070  Suicidal Cerbera odollam poisoning: a case report
    Angelika Holzer, Poisons Information Centre Austria, Vienna, Austria.
    Plant and Mushroom Poisoning

    081 A severe and prolonged case of Amanita phalloides poisoning
    Anja J Huusom, Department of Occupational and Environmental Medicine, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
    Plant and Mushroom Poisoning

    085  Facial paralysis after cutaneous burns from Heracleum mantegazzianum
    Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Plant and Mushroom Poisoning

    088  Does combining vitamin C and vitamin B17 (amygdalin) worsen toxicity?
    Faisal S Minhaj, Maryland Poison Center, Baltimore, United States.
    Plant and Mushroom Poisoning

    089  Confusion between toxic and edible plants registered by the French Poison Control Centres from 2012 to 2018
    Sandra Sinno-Tellier, Health Alerts and Vigilance department, French Agency for Food, Environmental and Occupational Health & Safety, MAISONS-ALFORT, France.
    Plant and Mushroom Poisoning

    090 Acute poisoning due to Datura ingestion: case report
    Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Plant and Mushroom Poisoning

    093  Severe plant poisonings admitted to the intensive care in France: management and outcome
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Plant and Mushroom Poisoning

    105  Toxicological evaluation of a cluster of reports of hepatitis related to turmeric dietary supplements in Italy
    Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Miscellaneous

    350 The White Panther: rare exposure to Amanita multisquamosa causing clinically significant toxicity
    Varun Vohra, Emergency Medicine, Michigan Poison Center, Wayne State University School of Medicine, Detroit, United States.
    Plant and Mushroom Poisoning

  • AFTERNOON Posters - Room 07
    008  Portal embolism in hydrogen peroxide ingestion: a case series
    Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Household Products Poisoning

    051 Artificial nail primer: a case series from Pavia Poison Control Centre
    Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Household Products Poisoning

    052 Nail glue: a beauty hazard
    Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
    Household Products Poisoning

    353  Accidental exposures to caustic drain cleaners
    Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
    Household Products Poisoning

    354  The “lactate gap” as a useful tool to detect ethylene glycol intoxications
    Dieter Geysels, Department of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
    Household Products Poisoning

    355 A one-year review of enquiries to the UK National Poisons Information Service involving cosmetic products
    Emma J Moyns, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
    Household Products Poisoning

    356  Acute ethylene glycol poisoning: a one year epidemiological study
    Julia V Radenkova - Saeva, Clinic of Toxicology, University Hospital for Emergency Medicine „ N.I.Pirogov”,, Sofia, Bulgaria.
    Household Products Poisoning

    357  Button battery ingestion: experience of the UK National Poisons Information Service (NPIS)
    Simon H L Thomas, National Poisons Information Service (Newcastle Unit), Regional Drugs and Therapeutics Centre, Newcastle upon Tyne, United Kingdom.
    Household Products Poisoning

  • AFTERNOON Posters - Room 08
    035  Amitraz: an unfamiliar insecticide with familiar toxicity
    William Rushton, Office of Medical Toxicology, University of Alabama at Birmingham, Birmingham, United States.
    Pesticide Poisoning

    040 The impact of obidoxime on duration of hospitalization in acute organophosphate poisoning in Muratsan University Hospital, Yerevan, Armenia, 2012-2019
    Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Pesticide Poisoning

    041 Poisoning risk of acute exposures to repellents: results from a prospective observational study
    Maren Hermanns-Clausen, Poisons Information Centre, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center – University of Freiburg, Freiburg, Germany.
    Pesticide Poisoning

    043  Organophosphate poisoning among children and adolescents in Armenia: a retrospective case study
    Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
    Pesticide Poisoning

    044  Lethal intoxication by pentachlorophenol
    Francesca Maida, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Pesticide Poisoning

    360 Evaluation of biocidal product enquiries to the Austrian Poisons Information Centre, 2017
    Tara Arif, Poisons Information Centre, Vienna, Austria.
    Pesticide Poisoning

  • AFTERNOON Posters - Room 09
    224  Two case of opioid withdrawal syndrome precipitated by alcohol dependence treatment with nalmefene successfully treated with morphine
    Jonas Moens, Belgian Poison Centre, Brussels, Belgium.
    Adverse reactions from medications

    228 Accidental injection of pseudorabies pigs vaccine in humans
    Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Adverse reactions from medications

    393 Iodoform medications may cause iodine toxicosis: two case reports
    Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Adverse reactions from medications

    394  Fooled by adrenaline: a pyrogenic-like reaction during treatment of a common European viper bite
    Anton Gustafsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
    Adverse reactions from medications

    395  Symptomatic therapeutic errors in the elderly: a case study
    Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Adverse reactions from medications

    396 Severe adverse effects after a second dose of paliperidone palmitate long-acting injectable administration: a case report
    Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Adverse reactions from medications

    397  Soft capsules formulated with ethanol: unexpected disulfiram-ethanol reaction after one dosage of ciclosporin
    Jonas Moens,Belgian Poison Control Centre, NEDER-OVER-HEEMBEEK, Belgium.
    Adverse reactions from medications

    398 Effect of a 12-hour intravenous acetylcysteine (SNAP) regimen on the International Normalized Ratio (INR)
    Ruben Thanacoody, Newcastle University, Newcastle Upon Tyne, United Kingdom.
    Adverse reactions from medications

  • AFTERNOON Posters - Room 10
    058  Sticky eye: a pediatric case of cyanoacrylate ocular exposure
    Presented By Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Spain.
    Paediatric Poisoning

    063 Pediatric cannabis poisonings in France: more and more frequent and severe.
    Gaël Le Roux, >Centre antipoison et Toxicovigilance Grand Ouest, CHU d'Angers, Angers, France.
    Paediatric Poisoning

    371 Childhood poisonings: five-years’ experience from an Italian pediatric emergency department
    Andrea Giampreti, Bergamo Poison Control Center, ASST Papa Giovanni XXIII, Bergamo, Italy.
    Paediatric Poisoning

    372  Fooled by adrenaline: a pyrogenic-like reaction during treatment of a common European viper bite
    Anton Gustafsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
    Adverse reactions from medications

    373  Altered mental status following a large ondansetron ingestion in a toddler
    Vincent Calleo, Emergency Medicine, SUNY Upstate Medical University, Syracuse, United States.
    Paediatric Poisoning

    374 Severe salicylic acid intoxication with a topical skin preparation in a newborn
    Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
    Paediatric Poisoning

    375  38 Weeks pregnant: managing a mother and neonate after a third-trimester acetaminophen ingestion
    Charlotte Goldfine, Emergency Medicine, Brigham and Women's Hospital, Boston, United States.
    Paediatric Poisoning

    376 Epidemiology of pediatric benzodiazepines exposures using the National Poison Data System
    Saumitra Rege, Department of Emergency Medicine, University of Virginia, Charlottesville, United States.
    Paediatric Poisoning

  • AFTERNOON Posters - Room 11
    104  Long-term exposure to Sargassum-seaweed pollution in the French Caribbean Islands: clinical consequences and outcome
    Dabor Resiere, Critical Care Medicine, University Hospital of Martinique, Fort de France, Martinique.
    Epidemiology of poisoning

    284 Latrodectus tredecemguttatus poisoning: a case report treated with antidote
    Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
    Toxinology (bites, stings, antivenom etc)

    285 Prolonged neurological effects after delayed antivenin administration
    Alfred Aleguas, Poison Information Center-Tampa, Tampa General Hospital, Tampa, United States.
    Toxinology (bites, stings, antivenom etc)

    286  Cardiovascular complications following ciguatera fish poisoning in the French West Indies: a case series
    Dabor Resiere, Critical Care Medicine, University Hospital of Martinique, Fort de France, Martinique.
    Toxinology (bites, stings, antivenom etc)

    287  Epidemiology of bites by indigenous venomous snakes in Switzerland reported to Tox Info Suisse over a 22 year period
    Joan Fuchs, Swiss National Poisons Information Center, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
    Toxinology (bites, stings, antivenom etc)

    289 An analysis of envenoming features in adder bite cases referred to the UK National Poisons Information Service (NPIS)
    David Stewart, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
    Toxinology (bites, stings, antivenom etc)

    290  Kambô: a healing potion or a poisonous toxin?
    Annie Watt, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
    Toxinology (bites, stings, antivenom etc)

    291 Viper bite neurotoxicity: two pediatric cases in central Italy
    Marco Marano, Emergency Department PICU. Regional Pediatric Poison Control Center., Bambino Gesù Children Hospital, Rome, Italy.
    Toxinology (bites, stings, antivenom etc)

    292 Thromboelastogram use in Crotalus adamanteus envenomation
    William F Rushton, Office of Medical Toxicology, Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, United States.
    Toxinology (bites, stings, antivenom etc)

    381 Rattlesnake bite in Austria: a case report
    Susanna Dorner-Schulmeister, Poisons Information Centre, Vienna, Austria.
    Toxinology (bites, stings, antivenom etc)

    382 Bitten abroad, an unforgettable souvenir: bites and stings reported to the UK National Poisons Information Service (NPIS) sustained whilst travelling overseas, 2009-2019
    Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
    Toxinology (bites, stings, antivenom etc)

  • AFTERNOON Posters - Room 12
    185  Valproic acid in the management of delirious, agitated critically ill toxicology patients
    Joseph J Rasimas, Consultation - Liaison Psychiatry, Hennepin County Medical Center, Minneapolis, United States.
    Miscellaneous

    186 Takotsubo syndrome during benzodiazepine withdrawal: a case report
    Francesco Gambassi, Medical Toxicology Unit and Poison Control Center, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
    Miscellaneous

    191 Myocardial infarction in the acutely poisoned patient: a case series
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Miscellaneous

    193  QTc interval and electrolyte derangement in alcohol withdrawal-related seizures
    Agnesa Mustafa, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
    Miscellaneous

    203   Emergent toxicological molecular screening test on ICU admission: can it be trusted?
    Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
    Analytical and Forensic Toxicology - including bedside testing

    211 The value of post-mortem toxicology in deciding whether a death is drug-induced
    James M Coulson, Clinical Pharmacology, Cardiff University, Cardiff, United Kingdom.
    Analytical and Forensic Toxicology - including bedside testing

    216  Laboratory practice variations complicate poison centre recommendations for massive paracetamol overdose
    Timothy C Backus, NYU School of Medicine, New York, United States.
    Analytical and Forensic Toxicology - including bedside testing

    218 Poison center recommendations for methylxanthine toxicity may be complicated by limited access to theophylline measurements
    Timothy C Backus, NYU School of Medicine, New York, United States.
    Analytical and Forensic Toxicology - including bedside testing

    361 Biological sample collection in the emergency department and laboratory substance abuse investigation and confirmation: a methamphetamine case report
    Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
    Analytical and Forensic Toxicology - including bedside testing

    362 Post-mortem ethanol concentrations
    James M Coulson, All Wales Therapeutics & Toxicology Centre, Cardiff University, Cardiff, United Kingdom.
    Analytical and Forensic Toxicology - including bedside testing